NCT05791110View on ClinicalTrials.gov

PE-1 in the Diagnosis of Pancreatic Exocrine Insufficiency

NACompletedINTERVENTIONAL
Enrollment

1,053

Participants

Timeline

Start Date

July 30, 2020

Primary Completion Date

May 30, 2021

Study Completion Date

August 26, 2021

Conditions
Pancreatic Exocrine Insufficiency
Interventions
DIAGNOSTIC_TEST

Fecal pancreatic elastase 1 test

Fecal pancreatic elastase 1 test are immunoassays for the quantitative determination of fecal pancreatic elastase in human stool samples.

Trial Locations (1)

200433

Changhai Hospital, Shanghai

All Listed Sponsors
collaborator

Xuanwu Hospital, Beijing

OTHER

collaborator

Peking Union Medical College Hospital

OTHER

lead

Changhai Hospital

OTHER

NCT05791110 - PE-1 in the Diagnosis of Pancreatic Exocrine Insufficiency | Biotech Hunter | Biotech Hunter